Changes in the Epidemiology of Pneumococcal Bacteremia in a Swiss University Hospital During a 15-Year Period, 1986-2000

From: Mayo Clinic Proceedings | Date: May 1, 2004| Author: Et al; Fluckiger, Ursula; Haenggi, Monika; Widmer, Andreas F; Trampuz, Andrej | Copyright information

* Objective: To evaluate changes in epidemiological characteristics and outcome of patients with pneumococcal bacteremia during a 15-year period in a Swiss university hospital.

* Patients and Methods: We reviewed the medical records of all hospitalized adults at the University Hospital Basel, Basel, Switzerland, whose blood culture yielded Streptococcus pneumoniae from January 1, 1986, through December 31, 2000.

* Results; We analyzed 405 episodes of pneumococcal bacteremia in 3...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Changes in the Epidemiology of Pneumococcal Bacteremia in a Swiss University Hospital During a 15-Year Period, 1986-2000
Mayo Clinic Proceedings ; * Objective: To evaluate changes in epidemiological characteristics and outcome of patients with pneumococcal bacteremia during a 15-year period in a Swiss university hospital. * Patients and Methods: We reviewed the medical records of all hospitalized adults at the University Hospital Basel,
Pneumococcal Bacteremia: Lessons Learned, Yet More to Learn
Mayo Clinic Proceedings ; Pneumoniathe Captain of the Men of Death Sir William Osler (1892) Few bacterial pathogens have affected the human condition more than Streptococcus pneumoniae, the most common pathogen in community-acquired pneumonia (CAP) worldwide and the leading cause of paranasal sinusitis, otitis media of
Pneumococcal bacteremia as a marker for HIV. (Tips from Other Journals)
American Family Physician ; Pneumococcal bacteremia is more common in patients with acquired immunodeficiency syndrome than in the general population. Chirurgi and colleagues believe that pneumococcal bacteremia may be a common presenting manifestation of human immunodeficiency virus (HIV) infection. The authors reviewed the
Antimicrobial agent resistance
Formulary ; ABSTRACT The emergence of antibiotic resistance to Streptococcus pneumoniae and other bacterial pathogens is, in part, responsible for the increase in infectious-disease-related mortality occurring between 1980 and 1992. Fluoroquinolones have provided an effective therapeutic option for infections
Clinical aspects of antimicrobial resistance
Mayo Clinic Proceedings ; Soon after penicillin was introduced into clinical use, an enzyme (penicillinase) that inactivated it was discovered. Since then, the variety of antimicrobial agents has increased substantially, along with a parallel increase in resistant pathogenic microorganisms. Resistance is now recognized
Is Combination the Only Issue?/From the Authors
American Journal of Respiratory and Critical Care Medicine ; We read with a lot of interest the article "Combination Antibiotic Therapy Lowers Mortality among Severely Critically Ill Patients with Pneumococcal Bacteremia" by Baddour and coworkers (1). Mono- or bitherapy in severe pneumonia is critical in our daily clinical practice, and this work provides
Current Approaches to Diagnosis and Treatment of Invasive Aspergillosis
American Journal of Respiratory and Critical Care Medicine ; ... 25 of 31 patients with invasive aspergillosis (81% sensitivity), and had a specificity of 89% (http://www.fda.gov/bbs/ topics/NEWS/2003/NEW00907.html). The lack of consistent results likely relate to different cutoff values for a positive result, differences ...
Antimicrobial resistance in Streptococcus pneumoniae: Implications for patients with community-acquired pneumonia
Mayo Clinic Proceedings ; Streptococcus pneumoniae is the leading cause of community-acquired pneumonia. During the past decade, the prevalence of penicillin resistance in S pneumoniae has increased dramatically, with resistance rates approaching 45% in some areas of the United States. Streptococcus pneumoniae has also
Emergency room-based pneumococcal vaccination program promises substantial savings, study finds
Formulary ; An emergency department (ED)-based pneumococcal vaccination program for high-risk patients can substantially reduce the incidence and costs of pneumococcal bacteremia, according to a new study. Pneumococcal bacteremia is a significant cause of morbidity and mortality in adults, but only 45.4% of US
Antifungal agents. Part II. The azoles
Mayo Clinic Proceedings ; ... an orally active triazole derivative with broad-spectrum antifungal activity. Its approval by the FDA in late 1992 was welcome news to clinicians. Major advantages over ketoconazole include greater activity against aspergillosis, sporotrichosis, cryptococcosis ...